Clinical TrialID 406
A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
NCT00483964
Schizophrenia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 406
- Evidence Id
- 406
- Core Evidence Id
- 406
- Source Clinical Trial Id
- 392
- Herb2 Clinical Trial Id
- HBCT000392
- Nct Id
- NCT00483964
- Title
- A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Schizophrenia
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Bacopa monnieri|DRUG: Nardostachys jatamansi|DRUG: Olanzapine
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 200
- Outcome Measure
- The change in the total PANSS score from baseline till the end of the study., 78 weeks
- Sponsor Collaborator
- Q.Mundewadi Ayurvedic Research & Charitable Trust|Stanley Medical Research Institute
- Funded By
- OTHER
- Location
- Q.Mundewadi Ayurvedic Research & Charitable Trust, Mumbra,Thane, Maharashtra, 400612, India
- Other Id
- SMRI #04T-512
- Start Date
- 2005-09
- Primary Completion Date
- Completion Date
- 2007-09
- First Posted
- 2007-06-08
- Results First Posted
- Last Update Posted
- 2007-10-10
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00483964
- Title Cn
- Title En
- A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
- Bilingual Status
- semi_complete